World

WHO halts malaria drug in COVID-19 trials

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. - REUTERS

Published: 5 Jul 2020